Poseida Therapeutics Inc (PSTX)
2.96
+0.15
(+5.34%)
USD |
NASDAQ |
May 14, 10:24
Poseida Therapeutics Profit Margin (Quarterly): -101.4% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -101.4% |
September 30, 2023 | -339.8% |
June 30, 2023 | -137.2% |
March 31, 2023 | -375.6% |
December 31, 2022 | -331.5% |
Date | Value |
---|---|
September 30, 2022 | 60.54% |
June 30, 2022 | -1.59K% |
March 31, 2022 | -4.05K% |
December 31, 2021 | 4.70% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.05K%
Minimum
Mar 2022
60.54%
Maximum
Sep 2022
-762.2%
Average
-331.5%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
Biomea Fusion Inc | -- |
Cartesian Therapeutics Inc | -973.0% |
Lantern Pharma Inc | -- |
NovaBay Pharmaceuticals Inc | -110.2% |
Palatin Technologies Inc | -385.6% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -87.19% |
Return on Assets | -40.53% |
Return on Invested Capital | -61.72% |
Operating Margin (Quarterly) | -103.7% |
Return on Net Operating Assets | -203.3% |